Dec 20, 2022 / 02:00PM GMT
Tim Metcalfe -
Well, good afternoon. It's now 2:01. So as I say, welcome to the Midatech Pharma shareholder webinar.
With me today, I've got Stephen Stamp, the CEO of Midatech; and Deborah Rathjen, who is the Executive Chair of Bioasis. My name is Tim Metcalfe. I'm Managing Director of IFC Advisory, Midatech's Financial PR and Investor Relations adviser.
This afternoon, Stephen and Deborah are going to take you through a presentation, giving you a lot more information, hopefully, in explaining some of the things about the proposed Bioasis transaction, the funding behind that and answering some of the questions that we've been submitted ahead of this webinar. However, we do encourage questions during the webinar. Given the number of people we've got attending, it's unfortunately not possible to go to individuals, ask you to unmute and put your questions directly. So I'd ask you please to use the Q&A button at the bottom of your screen, type in any question that you may have for either Stephen or Deborah, and I will ask those questions of them at the end of the presentation.
So
Midatech Pharma PLC Shareholder Webinar Transcript
Dec 20, 2022
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers